Eiger BioPharmaceuticals - 48 Year Dividend History | EIGR

Historical dividend payout and yield for Eiger BioPharmaceuticals (EIGR) since 1971. The current TTM dividend payout for Eiger BioPharmaceuticals (EIGR) as of June 14, 2019 is $0.00. The current dividend yield for Eiger BioPharmaceuticals as of June 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.195B $0.000B
Eiger BioPharmaceuticals, Inc. is a biopharmaceutical company which develops and manufactures drugs and therapies for the treatment of orphan diseases. Eiger BioPharmaceuticals, Inc., formerly known as Celladon Corporation, is based in Palo Alto, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83